Colombia vs United Arab Emirates: Drug use disorder deaths
Colombia
33.16 deaths
in 2021
United Arab Emirates
34.93 deaths
in 2021
Colombia rank
84th
United Arab Emirates rank
82nd
Drug use disorder deaths over time
- Colombia
- United Arab Emirates
How they compare
United Arab Emirates currently reports 34.93 deaths against 33.16 deaths in Colombia, a difference of 1.77 deaths.
That makes United Arab Emirates's figure about 1.1 times Colombia's.
Across all 22 years both countries report, United Arab Emirates has been ahead every year.
Colombia ranks 84th and United Arab Emirates ranks 82nd of 194 countries.
United Arab Emirates has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Colombia | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.14 deaths | 14.94 deaths | 10.81 deaths | United Arab Emirates |
| 2010s | 11.11 deaths | 37.34 deaths | 26.23 deaths | United Arab Emirates |
| 2020s | 32.89 deaths | 40.84 deaths | 7.95 deaths | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder deaths, Colombia or United Arab Emirates?
- United Arab Emirates, at 34.93 deaths against 33.16 deaths in Colombia as of 2021.
- What is the difference in drug use disorder deaths between Colombia and United Arab Emirates?
- 1.77 deaths, with United Arab Emirates ahead.
- How many years of comparable data are there for Colombia and United Arab Emirates?
- 22 years are reported by both, from 2000 to 2021.
- How do Colombia and United Arab Emirates rank globally for drug use disorder deaths?
- Colombia ranks 84th and United Arab Emirates ranks 82nd of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Drug use disorder deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from opioid use disorders in both sexes.